Pusch Emanuel, Renz Harald, Skevaki Chrysanthi
Institute of Laboratory Medicine and Pathobiochemistry, Member of the German Center for Lung Research (DZL), Philipps University Marburg, Baldingerstraße, 35043 Marburg, Germany.
Allergo J Int. 2018;27(3):79-96. doi: 10.1007/s40629-018-0056-0. Epub 2018 Mar 26.
To provide current knowledge on respiratory virus-induced heterologous immunity (HI) with a focus on humoral and cellular cross-reactivity. Adaptive heterologous immune responses have broad implications on infection, autoimmunity, allergy and transplant immunology. A better understanding of the mechanisms involved might ultimately open up possibilities for disease prevention, for example by vaccination.
A structured literature search was performed using Medline and PubMed to provide an overview of the current knowledge on respiratory-virus induced adaptive HI.
In HI the immune response towards one antigen results in an alteration of the immune response towards a second antigen. We provide an overview of respiratory virus-induced HI, including viruses such as respiratory syncytial virus (RSV), rhinovirus (RV), coronavirus (CoV) and influenza virus (IV). We discuss T cell receptor (TCR) and humoral cross-reactivity as mechanisms of HI involving those respiratory viruses. Topics covered include HI between respiratory viruses as well as between respiratory viruses and other pathogens. Newly developed vaccines which have the potential to provide protection against multiple virus strains are also discussed. Furthermore, respiratory viruses have been implicated in the development of autoimmune diseases, such as narcolepsy, Guillain-Barré syndrome, type 1 diabetes or myocarditis. Finally, we discuss the role of respiratory viruses in asthma and the hygiene hypothesis, and review our recent findings on HI between IV and allergens, which leads to protection from experimental asthma.
Respiratory-virus induced HI may have protective but also detrimental effects on the host. Respiratory viral infections contribute to asthma or autoimmune disease development, but on the other hand, a lack of microbial encounter is associated with an increasing number of allergic as well as autoimmune diseases. Future research might help identify the elements which determine a protective or detrimental outcome in HI-based mechanisms.
提供关于呼吸道病毒诱导的异源免疫(HI)的最新知识,重点关注体液和细胞交叉反应性。适应性异源免疫反应对感染、自身免疫、过敏和移植免疫学具有广泛影响。更好地理解其中涉及的机制可能最终为疾病预防开辟可能性,例如通过疫苗接种。
使用Medline和PubMed进行结构化文献检索,以概述关于呼吸道病毒诱导的适应性HI的当前知识。
在HI中,针对一种抗原的免疫反应会导致针对第二种抗原的免疫反应发生改变。我们概述了呼吸道病毒诱导的HI,包括呼吸道合胞病毒(RSV)、鼻病毒(RV)、冠状病毒(CoV)和流感病毒(IV)等病毒。我们讨论了T细胞受体(TCR)和体液交叉反应性作为涉及这些呼吸道病毒的HI机制。涵盖的主题包括呼吸道病毒之间以及呼吸道病毒与其他病原体之间的HI。还讨论了有可能提供针对多种病毒株保护的新开发疫苗。此外,呼吸道病毒与自身免疫性疾病的发生有关,如发作性睡病、格林-巴利综合征、1型糖尿病或心肌炎。最后,我们讨论了呼吸道病毒在哮喘和卫生假说中的作用,并回顾了我们最近关于IV与过敏原之间HI的发现,这导致对实验性哮喘的保护。
呼吸道病毒诱导的HI可能对宿主有保护作用,但也有不利影响。呼吸道病毒感染会导致哮喘或自身免疫性疾病的发展,但另一方面,缺乏与微生物的接触与越来越多的过敏性和自身免疫性疾病有关。未来的研究可能有助于确定在基于HI的机制中决定保护或有害结果的因素。